Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!
Cardiovascular Systems, Inc. (NASDAQ: CSII)
•Revenues of $28.8 million rose 26 percent over the fiscal 2012 fourth quarter, and 9 percent sequentially over the fiscal 2013 third quarter
•FDA questions were received on completed PMA application to treat coronary artery disease ?CSI submitted responses to FDA on July 19, 2013
Hey, check out all the research scientist jobs. Post your resume today!
Cardiovascular Systems, Inc. (NASDAQ: CSII)
•Revenues of $28.8 million rose 26 percent over the fiscal 2012 fourth quarter, and 9 percent sequentially over the fiscal 2013 third quarter
•FDA questions were received on completed PMA application to treat coronary artery disease ?CSI submitted responses to FDA on July 19, 2013
Hey, check out all the research scientist jobs. Post your resume today!
